Analytical Data
-
Gene name
CARD11
- Application
-
Alternative Names
CARMA1
-
Species
Human
-
Source
E. coli
-
Tag
Strep;His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9BXL7
-
Expression Region
A21-S116
-
Protein Length
Partial
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CARD11 (Caspase Recruitment Domain 11) is a critical adaptor protein involved in the activation of NF-κB signaling pathways, which play a fundamental role in immune response and cell survival. Mutations in the CARD11 gene have been associated with various immunological disorders, including immunodeficiencies and lymphoid malignancies. Researchers have increasingly focused on CARD11 due to its essential role in T cell receptor (TCR) and B cell receptor (BCR) signaling, where it facilitates the interaction of multiple signaling molecules to propagate downstream signaling cascades. Understanding the structure and function of CARD11 is crucial for elucidating its mechanisms of action and potential therapeutic targets. Recombinant protein production of CARD11 allows scientists to investigate its biochemical properties, interaction dynamics, and the effects of pathogenic mutations in controlled laboratory settings. By using techniques such as X-ray crystallography and cryo-electron microscopy, researchers can visualize the structure of CARD11, shedding light on how it mediates signal transduction in immune cells. Moreover, studying CARD11 through protein engineering and functional assays can provide insights into its regulation, contributing to the development of novel strategies for treating diseases linked to aberrant CARD11 function. Overall, the research on CARD11 and its recombinant protein presents significant implications for understanding immune system regulation and developing targeted therapies for related disorders.











